Dr. Amiran Gamkrelidze, Director-General of the NCDC in Georgia, uses IHME's COVID-19 projections to guide policy for the country.
IHME Director and lead modeler, Dr. Christopher J.L. Murray, shares insights from IHME's latest COVID-19 model run.
Chris Murray addresses how much there is still yet to learn about COVID-19.
Chris Murray addresses how much there is still yet to learn about COVID-19 with American Sign Language translation.
Governor Tim Walz of Minnesota uses the IHME COVID-19 model to inform policy decisions.
University of Washington Medicine's Michelle Moratti explains how her team worked with IHME to develop the first COVID-19 projections model.
University of Washington Medicine's Michelle Moratti explains how her team worked with IHME to develop the first COVID-19 projections model with American Sign Language translation.
Ryan Shackleton, the visualizations team leader, describes the first month of developing the COVID-19 projections tool.
Ryan Shackleton, the visualizations team leader, describes the first month of developing the COVID-19 projections tool with American Sign Language translation.
IHME Director Chris Murray reflects on what we've learned since the first projections model.
John Bridgeland, CEO of the COVID Collaborative, explains how their members use the weekly briefings to guide policy.
Dr. Alemnesh Mirkuzie discusses the impact of the COVID-19 and other models on public health in Ethiopia.
Dr. Alemnesh Mirkuzie discusses the impact of the COVID-19 and other models on public health in Ethiopia with American Sign Language translation.
IHME Engagement Officer Maja Pasovic reflects on the impact that COVID-19 has had and will continue to have on public health as a whole.
IHME Post Bachelor Fellow Lydia Haile discusses findings from a new research paper, "Global hearing loss prevalence and years lived with disability, 1990-2019: findings from the Global Burden of Disease 2019 Study."
IHME Professor Mohsen Naghavi says the best COVID-19 vaccine to get is the one available to you, when it's available to you.
Dr. Meghnath Dhimal, Chief Research Officer of the Nepal Health Research Council, discusses the how the council and Ministry of Health & Population utilizes Global Burden of Disease Study data and information.
Congratulations to Kristin Braa & Jørn Braa on being awarded the 2020 Roux Prize for turning evidence into health impact!
Dr. Mathilde Touvier, Head of the Nutritional Epidemiology Research at Sorbonne Paris Nord University, shares how the Global Burden of Disease study allows her research team to "efficiently improve nutritional prevention of chronic diseases."
Dr. Nafsiah Mboi, Minister of Health of Indonesia 2012-2014 and IHME Board Member, is a pediatrician and public health expert. She says that, "open access to the GBD data, and tools for analysis on the IHME website, has increased the number of people making use of data-based analysis and policy development for public health.
Professor John Newton, Director of Health Improvement at Public Health England, describes how the agency regularly provides insights and ideas to the annual Global Burden of Disease Study, and uses information from the study to influence health policy.
Professor Shuhei Nomura of the Department of Health Policy and Management at Keio University in Japan shares how he uses Global Burden of Disease Study data to advance health policy for prefectures, nationwide nutrition, and resource allocation.
Professor Peter Keiyoro of the University of Nairobi in Kenya, a collaborator of the Global Burden of Disease Study for six years, describes how the GBD has guided the Kenyan government into a national universal health coverage program. Additionally, GBD data laid the foundation for the Kenyan government to launch a pilot program that addresses water availability, sanitation, nutrition, child hygiene, under-five mortality, maternal health, and insurance coverage and health policies.
Dr. Cristiana Abbafati is a health economist at the University of Sapienza in Rome and a collaborator with the Global Burden of Disease Study. She utilizes GBD resources to better understand the relationship between Type II Diabetes, healthcare costs, and developmental levels in EU countries in order to recommend future health policies.
Global Burden of Disease Study, convened by the Institute for Health Metrics and Evaluation, is the most comprehensive global health study to date. It analyzes 286 causes of death, 369 diseases and injuries, and 87 risk factors in 204 countries and territories.